WonderAMP

The number of infections which are not treatable with traditional antibiotics has been steadily increasing over the past decade, with >1000 deaths caused by resistant infections in Australia in 2022. These infections present a pointed threat to the immunocompromised within our community, including the elderly and cancer patients while also placing additional strain on hospitals and general practitioners as novel cures need to be developed.

WonderAMP develops antimicrobial peptides specifically targeting these drug resistant bacteria strains to increase the quality of life for immunocompromised groups and slow the development of antimicrobial resistance.

Want to learn more or chat with the team? Reach out to WonderAMP’s team leader, Wenyi Li via wenyi.li@latrobe.edu.au

If you would like an introduction – we’re here to help! Contact the ON team via on@csiro.au.